Confining Prepared Ultrasmall Nanozymes Loading ATO for Lung Cancer Catalytic Therapy/Immunotherapy

• Published in: Advanced materials (Weinheim) Vol. 35; no. 45; pp. e2303722 - n/a
• Main Authors: Zhang, Amin, Gao, Ang, Zhou, Cheng, Xue, Cuili, Zhang, Qian, Fuente, Jesus M. De La, Cui, Daxiang
• Format: Journal Article
• Language: English
• Published: Weinheim Wiley Subscription Services, Inc 01.11.2023
• Subjects: ATO; Cancer; catalytic therapy; Hydrogen peroxide; ICD‐based immunotherapy; Immunotherapy; Light irradiation; Materials science; Nanocomposites; nPt nanozymes; Oxygen consumption; Peroxidase; Respiration; Serum albumin; Silicon dioxide
• ISSN: 0935-9648; 1521-4095
• DOI: 10.1002/adma.202303722

Nanozymes with inherent enzyme‐mimicking catalytic properties combat malignant tumor progression via catalytic therapy, while the therapeutic efficacy still needs to be improved. In this work, ultrasmall platinum nanozymes (nPt) in a confined domain of a wormlike pore channel in gold nanobipyramidal–mesoporous silica dioxide nanocomposites, producing nanozyme carriers AP‐mSi with photoenhanced peroxidase ability, are innovatively synthesized. Afterward, based on the prepared AP‐mSi, a lung‐cancer nanozymes probe (AP‐HAI) is ingeniously produced by removing the SiO2 template, modifying human serum albumin, and loading atovaquone molecules (ATO) as well as IR780. Under NIR light irradiation, inner AuP and IR780 collaborate for photothermal process, thus facilitating the peroxidase‐like catalytic process of H2O2. Additionally, loaded ATO, a cell respiration inhibitor, can impair tumor respiration metabolism and cause oxygen retention, hence enhancing IR780's photodynamic therapy (PDT) effectiveness. As a result, IR780's PDT and nPt nanozymes' photoenhanced peroxidase‐like ability endow probes a high ROS productivity, eliciting antitumor immune responses to destroy tumor tissue. Systematic studies reveal that the obvious reactive oxygen species (ROS) generation is obtained by the strategy of using nPt nanozymes and reducing oxygen consumption by ATO, which in turn enables lung‐cancer synergetic catalytic therapy/immunogenic‐cell‐death‐based immunotherapy. The results of this work would provide theoretical justification for the practical use of photoenhanced nanozyme probes. Ultrasmall nPt nanozymes are innovatively fabricated upon AuP via a SiO2 spatial confinement strategy, and then modified with human serum albumin, followed by loading atovaquone molecules, and encapsulating IR780 in succession, to design AP‐HAI probes in which the IR780's PDT property and the nPt nanozymes' photoenhanced peroxidase‐like ability endow probes with a high reactive oxygen species (ROS) productivity, which results in outstanding lung‐cancer synergetic catalytic therapy/immunogenic‐cell‐death‐based immunotherapy.